Допамін (лікарський засіб) (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Допамін (лікарський засіб)" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

9nih.gov

4^th place

5^th place

8doi.org

2^nd place

4^th place

5web.archive.org

1^st place

2books.google.com

3^rd place

11^th place

2archive.org

6^th place

1guidetopharmacology.org

low place

1compendium.com.ua

low place

238^th place

1drugs.com

399^th place

754^th place

1fpnotebook.com

low place

archive.org

Bhatt-Mehta V, Nahata MC (1989). Dopamine and dobutamine in pediatric therapy. Pharmacotherapy. 9 (5): 303—314. doi:10.1002/j.1875-9114.1989.tb04142.x. PMID 2682552.
Sax's Dangerous Properties of Industrial Materials, 11th Ed. Hoboken, NJ.: Wiley & Sons. 2004. с. 1552. ISBN 978-0-471-47662-7.

books.google.com

Biochemistry explained : a practical guide to learning biochemistry. London: Routledge. 2002. с. 40. ISBN 9780415299411. Архів оригіналу за 15 серпня 2016.
Clinical Cardiology: Current Practice Guidelines (англ.). OUP Oxford. 19 вересня 2013. с. 314. ISBN 9780191508516. Архів оригіналу за 6 травня 2016. Dopamine binds to beta-1, beta-2, alpha-1 and dopaminergic receptors.

compendium.com.ua

ДОПАМІН (DOPAMINUM) Діюча речовина

doi.org

Bhayat SI, Gowda HM, Eisenhut M (May 2016). Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence. World Journal of Clinical Pediatrics. 5 (2): 212—222. doi:10.5409/wjcp.v5.i2.212. PMC 4857235. PMID 27170932.
De Backer D, Aldecoa C, Njimi H, Vincent JL (March 2012). Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Critical Care Medicine. 40 (3): 725—730. doi:10.1097/ccm.0b013e31823778ee. PMID 22036860.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM та ін. (February 2013). Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine. 41 (2): 580—637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941.
Fahn S (2008). The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders. 23 (Suppl 3): S497—S508. doi:10.1002/mds.22028. PMID 18781671. According to Hornykiewicz,6 dopamine was first synthesized by George Barger and James Ewens in 1910 at the Wellcome labs in London, England.
Karthik S, Lisbon A (2006). Low-dose dopamine in the intensive care unit. Seminars in Dialysis. 19 (6): 465—471. doi:10.1111/j.1525-139X.2006.00208.x. PMID 17150046.
Bhatt-Mehta V, Nahata MC (1989). Dopamine and dobutamine in pediatric therapy. Pharmacotherapy. 9 (5): 303—314. doi:10.1002/j.1875-9114.1989.tb04142.x. PMID 2682552.
Deng WP, Wong KA, Kirk KL (2002). Convenient syntheses of 2-, 5- and 6-fluoro- and 2,6-difluoro-L-DOPA. Tetrahedron: Asymmetry. 13 (11): 1135—1140. doi:10.1016/S0957-4166(02)00321-X.
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C та ін. (March 2010). Comparison of dopamine and norepinephrine in the treatment of shock. The New England Journal of Medicine. 362 (9): 779—789. doi:10.1056/NEJMoa0907118. PMID 20200382.

drugs.com

Dopamine Hydrochloride. drugs.com. American Society of Health-System Pharmacists. 29 червня 2016. Архів оригіналу за 14 вересня 2016. Процитовано 15 липня 2016.

fpnotebook.com

Dopamine. Family Practice Notebook. Архів оригіналу за 1 лютого 2016. Процитовано 1 лютого 2016. Dopamine binds to alpha-1 and beta-1 adrenergic receptors. Mediated through myocardial beta-1 adrenergic receptors, dopamine increase heart rate and force, thereby increasing cardiac output. Alpha-1 adrenergic receptor stimulation on vascular smooth muscle, leads to vasoconstriction and results in an increase in systemic vascular resistance

guidetopharmacology.org

Dopamine: Biological activity. IUPHAR/BPS guide to pharmacology. International Union of Basic and Clinical Pharmacology. Архів оригіналу за 5 лютого 2016. Процитовано 29 січня 2016.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bhayat SI, Gowda HM, Eisenhut M (May 2016). Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence. World Journal of Clinical Pediatrics. 5 (2): 212—222. doi:10.5409/wjcp.v5.i2.212. PMC 4857235. PMID 27170932.
De Backer D, Aldecoa C, Njimi H, Vincent JL (March 2012). Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Critical Care Medicine. 40 (3): 725—730. doi:10.1097/ccm.0b013e31823778ee. PMID 22036860.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM та ін. (February 2013). Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine. 41 (2): 580—637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941.
Fahn S (2008). The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders. 23 (Suppl 3): S497—S508. doi:10.1002/mds.22028. PMID 18781671. According to Hornykiewicz,6 dopamine was first synthesized by George Barger and James Ewens in 1910 at the Wellcome labs in London, England.
Karthik S, Lisbon A (2006). Low-dose dopamine in the intensive care unit. Seminars in Dialysis. 19 (6): 465—471. doi:10.1111/j.1525-139X.2006.00208.x. PMID 17150046.
Power DA, Duggan J, Brady HR (April 1999). Renal-dose (low-dose) dopamine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Clinical and Experimental Pharmacology & Physiology. Supplement. 26: S23—S28. PMID 10386250.
Bhatt-Mehta V, Nahata MC (1989). Dopamine and dobutamine in pediatric therapy. Pharmacotherapy. 9 (5): 303—314. doi:10.1002/j.1875-9114.1989.tb04142.x. PMID 2682552.
De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C та ін. (March 2010). Comparison of dopamine and norepinephrine in the treatment of shock. The New England Journal of Medicine. 362 (9): 779—789. doi:10.1056/NEJMoa0907118. PMID 20200382.

ncbi.nlm.nih.gov

Bhayat SI, Gowda HM, Eisenhut M (May 2016). Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence. World Journal of Clinical Pediatrics. 5 (2): 212—222. doi:10.5409/wjcp.v5.i2.212. PMC 4857235. PMID 27170932.

web.archive.org

Dopamine: Biological activity. IUPHAR/BPS guide to pharmacology. International Union of Basic and Clinical Pharmacology. Архів оригіналу за 5 лютого 2016. Процитовано 29 січня 2016.
Dopamine Hydrochloride. drugs.com. American Society of Health-System Pharmacists. 29 червня 2016. Архів оригіналу за 14 вересня 2016. Процитовано 15 липня 2016.
Biochemistry explained : a practical guide to learning biochemistry. London: Routledge. 2002. с. 40. ISBN 9780415299411. Архів оригіналу за 15 серпня 2016.
Dopamine. Family Practice Notebook. Архів оригіналу за 1 лютого 2016. Процитовано 1 лютого 2016. Dopamine binds to alpha-1 and beta-1 adrenergic receptors. Mediated through myocardial beta-1 adrenergic receptors, dopamine increase heart rate and force, thereby increasing cardiac output. Alpha-1 adrenergic receptor stimulation on vascular smooth muscle, leads to vasoconstriction and results in an increase in systemic vascular resistance
Clinical Cardiology: Current Practice Guidelines (англ.). OUP Oxford. 19 вересня 2013. с. 314. ISBN 9780191508516. Архів оригіналу за 6 травня 2016. Dopamine binds to beta-1, beta-2, alpha-1 and dopaminergic receptors.